Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of a 4-week fludrocortisone (FLU) treatment on systolic blood
pressure depression after 5 minutes of active orthostatism in patients with neurogenic
orthostatic hypotension (HON) symptomatic, despite treatment with non-drug measures with or
without midodrine.